Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$234.79 +1.78 (+0.76%)
As of: Oct 2, 2026 · 10:32 AM EDT

Jazz Pharmaceuticals (JAZZ) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Jazz Pharmaceuticals (JAZZ) recorded Depreciation & Amortization (CF) of $9.1 million in Q2 2026, down 23.5% from $11.9 million a year earlier and unchanged from the prior quarter.

Analysis

Jazz Pharmaceuticals (JAZZ) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a TTM basis, Jazz Pharmaceuticals' Depreciation & Amortization (CF) came in at $37.54 million as of Jun 30, 2026, down 5.2% year-over-year; for FY2025, it was $41.64 million, up 27.1% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for 14 straight years, with a five-year compound annual growth rate of 17.4% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $32.75 million in FY2024 (+7.7%), $30.41 million in FY2023 (+0.4%), $30.3 million in FY2022 (+13.4%) and $26.71 million in FY2021 (+43.1%).
  • Quarterly Depreciation & Amortization (CF) has ranged from $7.33 million in Q4 2021 to $11.9 million in Q2 2025 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined for three consecutive quarters, with growth averaging 13.1% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 61.6% in Q3 2021, against a decline of 23.5% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $9.1 million (Q1 2026), $9.43 million (Q4 2025) and $9.91 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Jazz Pharmaceuticals 15.03 Bn 8.85 Bn 1.09 Bn 9.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.10 Mn
Mar 31, 2026 9.10 Mn
Dec 31, 2025 9.43 Mn
Sep 30, 2025 9.91 Mn
Jun 30, 2025 11.90 Mn
Mar 31, 2025 10.40 Mn
Dec 31, 2024 9.51 Mn
Sep 30, 2024 7.78 Mn
Jun 30, 2024 7.81 Mn
Mar 31, 2024 7.65 Mn
Dec 31, 2023 7.65 Mn
Sep 30, 2023 7.68 Mn
Jun 30, 2023 7.52 Mn
Mar 31, 2023 7.57 Mn
Dec 31, 2022 7.34 Mn
Sep 30, 2022 7.59 Mn
Jun 30, 2022 7.75 Mn
Mar 31, 2022 7.62 Mn
Dec 31, 2021 7.33 Mn
Sep 30, 2021 7.77 Mn
API Access

Jazz Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=JAZZ&period=max&api_key=YOUR_API_KEY